Tofacitinib in Recurrent GBM Patients
Clinical trial NCT05326464 · COMPLETED
Trial details
- NCT number
- NCT05326464
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-07
- Primary completion
- 2025-02-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.